TG Therapeutics | Resultado Líquido

Net Income Alterar Data
AbbVie USD 1.37B 547M 2024-03
Amgen USD -113000000 880M 2024-03
Ardelyx USD -26518000 33.15M 2024-03
Arrowhead Research USD -125300000 7.56M 2024-03
Bayer EUR 2B 663M 2024-03
Biogen USD 393.4M 143.7M 2024-03
Corcept Therapeutics USD 27.76M 3.59M 2024-03
Dynavax Technologies USD -8721000 8.94M 2024-03
Gilead Sciences USD -4170000000 5.6B 2024-03
J&J USD 3.26B 794M 2024-03
Novartis USD 2.69B 5.79B 2024-03
PTC Therapeutics USD -91576000 64.22M 2024-03
Regeneron Pharmaceuticals USD 722M 437.6M 2024-03
Roche Holding CHF 7.14B 3.25B 2023-06
TG Therapeutics USD -10707000 3.71M 2024-03
Vertex Pharmaceuticals USD 1.1B 64.3M 2024-03



TG Therapeutics Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.